BIOTECH Logo

BIOTECH

A biotechnology group offering preclinical services, intein development, and licensing.

BST | BME Growth

Overview

Corporate Details

ISIN(s):
ES0184980003 (+1 more)
LEI:
959800GNYT6ZZEWPEW29
Country:
Spain
Address:
AVDA. DEL DESARROLLO TECNOLOGICO (PARQUE CIENTIFICO TECNOLOGICO AGROINDUSTRIAL) 11, 11591 Jerez de la Frontera

Description

Biotechnology Assets Biat Group is a biotechnology corporate group with a global commercial structure operating through several subsidiaries. Its subsidiary Biobide is a provider of preclinical services, specializing in tailor-made toxicity and efficacy testing using the zebrafish (ZF) animal model. ZIP Solutions develops and promotes a proprietary set of inteins for high-value industrial applications, including gene therapy, immunotherapy, in-vitro diagnostics, smart vaccines (RNA & DNA), and affinity-based protein purification. The Bionatur division manages biotech assets for human and animal health. The group focuses on licensing its platforms and products, conducting preclinical research, and improving recombinant and DNA vaccines through collaborations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-03-19 14:18
Net Asset Value(s)
English 4.0 KB
2025-03-18 10:30
Net Asset Value(s)
English 4.0 KB
2025-03-17 14:38
Net Asset Value(s)
English 4.0 KB
2025-03-14 10:53
Net Asset Value(s)
English 4.0 KB
2025-03-13 15:33
Net Asset Value(s)
English 4.0 KB
2025-03-12 14:50
Net Asset Value(s)
English 4.1 KB
2025-03-11 15:54
Net Asset Value(s)
English 4.0 KB
2025-03-10 14:35
Net Asset Value(s)
English 4.0 KB
2025-03-07 14:28
Net Asset Value(s)
English 4.0 KB
2025-03-07 09:08
Net Asset Value(s)
English 4.0 KB
2025-03-06 15:30
Net Asset Value(s)
English 4.0 KB
2025-03-06 08:00
Net Asset Value(s)
English 4.0 KB
2025-03-05 14:34
Net Asset Value(s)
English 4.0 KB
2025-03-04 14:40
Net Asset Value(s)
English 4.0 KB
2025-03-03 15:43
Net Asset Value(s)
English 4.0 KB

Automate Your Workflow. Get a real-time feed of all BIOTECH filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOTECH

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOTECH via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Rafael Holdings, Inc. Logo
Invests in and develops therapies for cancer and rare genetic disorders.
United States of America
RFL
Rain Enhancement Technologies Holdco, Inc. Logo
Develops ionization-based weather modification technology for rainfall generation.
United States of America
RAIN
Rallybio Corp Logo
A clinical-stage biotech company developing therapies for severe and rare diseases.
United States of America
RLYB
RaQualia Pharma Inc. Logo
Develops and out-licenses innovative small molecule drug compounds.
Japan
4579
RECURSION PHARMACEUTICALS, INC. Logo
A clinical-stage company applying AI and machine learning to drug discovery.
United States of America
RXRX
RELMADA THERAPEUTICS, INC. Logo
Clinical-stage biotech developing therapies for bladder cancer and compulsive disorders.
United States of America
RLMD
RenovoRx, Inc. Logo
A clinical-stage company developing targeted oncology therapies for solid tumors.
United States of America
RNXT
Repare Therapeutics Inc. Logo
A clinical-stage oncology company developing targeted cancer therapies.
United States of America
RPTX
Replimune Group, Inc. Logo
A clinical-stage biotech developing oncolytic immunotherapies to treat cancer.
United States of America
REPL
ReproCELL Incorporated Logo
Provider of stem cell technology and services for research and regenerative medicine.
Japan
4978

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.